Search database
Filter
124
Text search: delamanid
Featured
Language
Document type
76
17
12
8
4
2
2
2
1
Countries / Regions
14
11
4
3
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
29
13
5
4
4
4
3
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Publication Years
Category
31
19
3
1
1
Toolboxes
105
5
3
2
2
1
1
1
1
1
1
1
The END TB Strategy
The End TB Strategie
Ciudad de México, México - 26 al 28 de mayo del 2014

Review of the national tuberculosis programme in Belarus

P. de Colombani World Health Organization Europe (2016) C_WHO
8–18 December 2015
4–15 February 2013
Elaborat în cadrul proiectului „Fortificarea controlului tuberculozei în Moldova”, finanţat de către Fondul Global de combatere a SIDA, Tuberculozei şi Malariei.
Eine Leitlinie zur Diagnostik und Therapie, einschließlich Chemoprävention und -prophylaxe des Deutschen Zentralkomitees zur Bekämpfung der Tuberkulose e.V. im Auftrag der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e.V. Tuberculosis Guideline for Adults Guideline for Diagnosis ... more
Epidemiologisches Bulletin; 14. März 2016 Nr. 10/11 ;DOI 10.17886/EpiBull-2016-014
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
Version: 24 April 2018
A survey of prevention, testing and treatment policies and practices
2nd edition. T The Compendium has been developed as a clear and concise instrument to facilitate the understanding and planning of delivery of high-quality care for everybody affected by TB. It incorporates all recent policy guidance from WHO; follows the care pathway of persons with signs or sympt ... more
The WHO South-East Asia (‎SEA)‎ Region bears a high burden of tuberculosis (‎TB)‎ and MDR-TB. In 2015, the Region accounted for nearly 200 000 or 35% of the global estimated new RR/MDR-TB cases eligible for treatment. Extensively drug-resistant TB (‎XDRTB)‎ has also been reported from s ... more
TB remains one of the world’s deadliest infectious diseases, second only to COVID-19, and drug-resistant TB strains are still a major concern. In the fight against TB, urgent investment is critical, especially in the context of the ongoing pandemic.